SEC v. Daniel V.T. Catenacci (insider trading, 2021)

Settled

✓ Checked against the primary document on October 4, 2026. The library's summary, tags and figures for this record were compared with the regulator's own document by an AI model (Claude) following written instructions, with sampled and disputed records read a second time. No lawyer has reviewed them. A checked record can still contain errors, and checked does not mean endorsed. See how we check records or report a correction.

Report an error in this record (sec-daniel-v-t-catenacci-insider-trading-2021) by email

In December 2021 the SEC sued Chicago physician Daniel Catenacci over alleged insider trading in Five Prime Therapeutics ahead of a November 2020 drug-trial announcement. On August 18, 2023 he consented to a final judgment with an injunction and a $50,000 penalty.

The record

What was ordered

Civil penalty

$50k

Disgorgement

—

Prejudgment interest

—

Total relief

$50k

Alleged gain

—

A dash means the release did not state a figure we could extract, not that the figure is zero. Penalty and disgorgement are stored separately so aggregates across the library do not double-count the same dollars.

What is alleged to have happened

the Securities and Exchange Commission announced this matter on December 20, 2021 as release LR-25291. The respondents named are Daniel V.T. Catenacci (1 individual, 0 entities).

This library tags the matter as insider trading, based on the conduct the regulator describes. Each tag links to a page explaining how that technique works, what statute it engages, and what penalties comparable actions have attracted. The tagging is ours, not the regulator's: agencies charge statutory provisions, not technique names.

The conduct is recorded against equities.

The release references a parallel criminal proceeding. Where a criminal case exists, the civil and criminal outcomes are recorded separately, because they resolve on different standards of proof.

Outcome: SEC release LR-25813 (August 21, 2023) says the Northern District of Illinois entered a final judgment on August 18, 2023 to which Catenacci consented without admitting or denying the allegations. It permanently enjoins him from violating Section 10(b) and Rule 10b-5 and orders a $50,000 civil penalty. The release puts his alleged gain at $134,142; no disgorgement is reported.

What technique is this, and how does it work?

This action is tagged with one technique in our taxonomy. The tagging is ours: regulators charge statutory provisions, not technique names, so the mapping is an editorial judgement described in our editorial policy.

• Insider trading — see how it works, what statute it engages, and every other action tagged the same way.

Timeline

1. 2021-12-20 Litigation release published
2. 2023-08-18 Final judgment on consent entered (N.D. Ill.), announced in LR-25813

Primary documents

Everything on this page derives from the documents below. Where our summary and the primary document disagree, the primary document is right.

• SEC litigation release
• SEC litigation release LR-25813 (final judgment)

The linked release is a work of the United States government and is not subject to copyright. Our summary and narrative above are our own writing.

Same matter

The library links these 2 records because they appear to concern one matter: the same lead defendant, an overlapping technique tag and close filing dates, or a shared court docket or a release that cites the other. Records are listed by date filed.

This grouping is the library's, made by matching names, techniques, dates and citations when the site is built. It is not the regulator's or a court's determination that the records are one case, and it errs towards missing a link rather than making a false one.

Related actions

Other actions in the library sharing at least one technique tag with this one.

Record added September 10, 2026. submit a correction.